ConductScience.org, home

Paper42436136

Specimen quality shapes the actionable genomic landscape in comprehensive cancer genomic profiling.

Nakahara H and 6 others. NPJ Genom Med, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Specimen quality shapes the actionable genomic landscape in comprehensive cancer genomic profiling. Papers, record 42436136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42436136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Specimen quality shapes the actionable genomic landscape in comprehensive cancer genomic profiling.
PubMed
Journal
NPJ Genom Med
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-06
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nakahara HHikaru
2Niitsu HHiroaki
3Motonaga MMasanori
4Matsuo HHiroaki
5Arihiro KKoji
6Hayes CNC Nelson
7Hinoi TTakao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
JP26K18769Japan Society for the Promotion of SciencePubMed

Source PubMed

Download CSV of grants

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140783289Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial.Lancet2025https://conductscience.org/library/papers/40783289PubMed
240335734The usefulness of comprehensive genome profiling test in screening of Lynch syndrome independent of the conventional clinical screening or microsatellite instability tests.J Hum Genet2025https://conductscience.org/library/papers/40335734PubMed
333431880Construction and integration of three de novo Japanese human genome assemblies toward a population-specific reference.Nat Commun2021https://conductscience.org/library/papers/33431880PubMed
436040493Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice.Clin Cancer Res2022https://conductscience.org/library/papers/36040493PubMed
540938919Analytical validation (accuracy, reproducibility, limit of detection) and gene expression analysis of FoundationOneRNA assay for fusion detection in 189 clinical tumor specimens.PLoS One2025https://conductscience.org/library/papers/40938919PubMed
634339623Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.Lancet Oncol2021https://conductscience.org/library/papers/34339623PubMed
737795443The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality.Front Oncol2023https://conductscience.org/library/papers/37795443PubMed
828132688InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines.Am J Hum Genet2017https://conductscience.org/library/papers/28132688PubMed
939939621Real-world data analysis for factors influencing the quality check status in FoundationOne CDx cancer genomic profiling tests.Sci Rep2025https://conductscience.org/library/papers/39939621PubMed
1033762738Clinical cancer genomic profiling.Nat Rev Genet2021https://conductscience.org/library/papers/33762738PubMed
1136328033Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14).Lancet Gastroenterol Hepatol2023https://conductscience.org/library/papers/36328033PubMed
1237256976Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.N Engl J Med2023https://conductscience.org/library/papers/37256976PubMed
1340140952Real-World Data Analysis of Genomic Alterations Detected by a Dual DNA-RNA Comprehensive Genomic Profiling Test.Cancer Sci2025https://conductscience.org/library/papers/40140952PubMed
1440634197Genomic Landscape of Resected Invasive Mucinous Adenocarcinoma of the Lung.Clin Lung Cancer2025https://conductscience.org/library/papers/40634197PubMed
1537276871Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.Lancet Oncol2023https://conductscience.org/library/papers/37276871PubMed
1636746967Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.Nat Commun2023https://conductscience.org/library/papers/36746967PubMed
1732788553Cancer genomic medicine in Japan.Proc Jpn Acad Ser B Phys Biol Sci2020https://conductscience.org/library/papers/32788553PubMed
1840848312The emerging role of PARP inhibitors in prostate cancer: A narrative review.Cancer Treat Rev2025https://conductscience.org/library/papers/40848312PubMed
1939366135Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development.Cancer Treat Rev2024https://conductscience.org/library/papers/39366135PubMed
2032213540Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors.Cancer Discov2020https://conductscience.org/library/papers/32213540PubMed

See all 43 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42436136

GET https://conductscience.org/api/papers/v1/42436136/references?page=2